3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
3
Terminated
2
Withdrawn
1
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Neoplasms
23
Venous Thromboembolism
20
Febrile Neutropenia
20
Anemia
20
Thrombocytopenia
15
Myelodysplastic Syndromes
14
Leukemia, Myeloid, Acute
14
Lymphoma
12
Leukemia
12
Anemia, Refractory, with Excess of Blasts
10
Anemia, Aplastic
10
Colorectal Neoplasms
9
Breast Neoplasms
8
Anemia, Iron-Deficiency
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Anemia, Sickle Cell
7
Neutropenia
6
Multiple Myeloma
6
Ovarian Neoplasms
5
Neoplasms, Plasma Cell
5
Lymphoma, Follicular
5
Hematologic Neoplasms
5
Fanconi Anemia, Complementation Group D1
5
Hemophilia A
4
Chemotherapy-induced Thrombocytopenia
4
Stroke
3
Pulmonary Disease, Chronic Obstructive
3
Parkinson Disease
3
Osteoporosis
3
Multiple Sclerosis
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Primary Immunodeficiency Diseases
×
Classical hematology
×
Clear all
NCT03836690
2019-10-25
ToTem
University College, London
Phase 1
Unknown
18 enrolled